Xgeva 120 MG/1.7 ML vial 1.7ML
Ended Awarded
- Contract number
- SPE2DB25FKA41
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $105,026
Award facts
- Contract value 100% obligated
- $105,026.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $105,026.01 to AmerisourceBergen Drug Corp for the supply of XGEVA 120 mg/1.7 ml vials. This competitively awarded, firm fixed-price contract was executed on September 22, 2025, with an ultimate completion date of September 23, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that establishes the company as a comprehensive global pharmaceutical support vehicle for military healthcare needs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated substantial capability in federal medical procurement through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency. The company supplies a broad range of pharmaceutical products and medical commodities—including specialty medications, vaccines, and medical devices—to support military healthcare systems and the Defense Health Agency. This delivery order for XGEVA, a bone health medication, exemplifies the company's role as a critical vendor in the federal supply chain for specialized pharmaceutical products across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FKA41?
SPE2DB25FKA41 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FKA41 worth?
The government has obligated $105,026 on SPE2DB25FKA41.
Is contract SPE2DB25FKA41 an order under another contract?
Yes. SPE2DB25FKA41 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FKA41 competed?
The extent of competition for SPE2DB25FKA41 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award